Combination of Rearrangement with Metallic and Organic Catalyses
= 6.7, 6.9, 10.2, 17.0 Hz, 1 H), 5.16–5.01 (m, 2 H), 4.17 (dd, J = (CH), 117.2 (CH2), 97.7 (C), 63.1 (CH2), 33.0 (CH2), 29.9 (CH2),
6.7, 6.8 Hz, 2 H), 3.13 (dd, J = 8.8, 9.0 Hz, 1 H), 2.53–2.01 (m, 6
27.0 (CH2), 22.3 (CH2), 21.9 (CH2) ppm. 1H NMR (300 MHz,
H), 1.93–1.77 (m, 2 H) ppm. MS (ESI+): m/z = 183 [M + H]+, 205 CDCl3): δ = 12.16 (s, 0.9 H), 5.80 (dddd, J = 6.8, 6.9, 10.2, 17.0 Hz,
[M + Na]+, 221 [M + K]+.
0.9 H), 5.71 (dddd, J = 6.7, 6.9, 10.2, 17.1 Hz, 0.1 H), 5.16–4.98
(m, 2 H), 4.18 (dd, J = 6.7, 6.7 Hz, 1.8 H), 4.14–4.10 (m, 0.2 H),
3.38–3.33 (m, 0.1 H), 2.41 (dddd, J = 1.2, 1.3, 6.8, 13.4 Hz, 2 H),
2.28–2.16 (m, 4 H), 1.72–1.54 (m, 4 H) ppm. MS (ESI+): m/z =
197 [M + H]+, 219 [M + Na]+, 235 [M + K]+.
Compound 3d: According to the general procedure, 3d was obtained
as a colourless oil (167 mg, 58%). Rf (30% EtOAc in petroleum
ether) = 0.42. 13C NMR (75 MHz, CDCl3): δ = 207.0 (C), 206.8
(C), 166.3 (C), 165.8 (C), 160.8 (2 C), 148.6 (C), 148.6 (C), 132.6
(CH), 132.2 (CH), 130.1 (2CH), 117.5 (CH2), 116.9 (CH2), 105.8
(2 CH), 103.3 (2 CH), 99.3 (2 CH), 55.8 (CH2), 55.7 (CH2), 55.1
Compound 3i: According to the general procedure, 3i was obtained
as a colourless oil (135 mg, 74% for Table 1, and 171 mg, 94% for
(2 CH3), 52.3 (CH2), 51.6 (CH2), 51.3 (CH), 50.6 (CH), 49.0 (CH2), Table 2). Rf (20% EtOAc in petroleum ether) = 0.57–0.86. 13C
48.7 (CH2), 35.2 (CH3), 34.3 (CH3) ppm. 1H NMR (300 MHz,
CDCl3): δ = 7.19 (dd, J = 8.2, 8.2 Hz, 2 H), 6.40 (dd, J = 2.3, (C), 131.7 (CH), 118.4 (CH2), 65.6 (CH2), 57.1 (CH), 41.4 (CH2),
NMR (75 MHz, CDCl3): keto form (ca. 30%): δ = 206.0 (C), 169.6
8.0 Hz, 2 H), 6.29 (ddd, J = 2.3, 2.6, 7.9 Hz, 2 H), 6.25–6.20 (m, 2
H), 5.93–5.69 (m, 2 H), 5.30–5.14 (m, 4 H), 4.14–3.70 (m, 14 H),
3.8 (s, 6 H), 3.15 (s, 3 H), 3.0 (s, 3 H) ppm. MS (ESI+): m/z = 289
[M + H]+, 311 [M + Na]+, 227 [M + K]+.
29.9 (CH2), 27.0 (CH2), 23.2 (CH2); enol form (ca. 70%): δ = 172.4
(C), 172.2 (C), 132.2 (CH), 117.7 (CH2), 97.5 (C), 64.6 (CH2), 29.0
(CH2), 22.3 (CH2), 22.3 (CH2), 21.8 (CH2) ppm. 1H NMR
(300 MHz, CDCl3): δ = 12.13 (s, 0.7 H), 5.95 (dddd, J = 5.5, 6.7,
10.5, 17.2 Hz, 0.7 H), 5.91 (dddd, J = 5.8, 6.0, 10.5, 17.2 Hz, 0.3
H), 5.27 (dddd, J = 1.4, 1.5, 10.5, 17.2 Hz, 1.4 H), 5.40–5.10 (m,
0.6 H), 4.65 (ddd, J = 1.4, 1.5, 5.5 Hz, 1.4 H), 4.75–4.55 (m, 0.6
H), 3.41 (m, 0.3 H), 2.56–2.45 (m, 0.3 H), 2.42–2.10 (m, 3.7 H),
1.94–1.77 (m, 0.3 H), 1.72–1.56 (m, 3.7 H) ppm. MS (ESI+): m/z
= 197 [M + H]+, 219 [M + Na]+, 235 [M + K]+.
Compound 3e: According to the general procedure, 3e was obtained
as a colourless oil (134 mg, 63%). Rf (60% EtOAc in petroleum
ether) = 0.65. 13C NMR (75 MHz, CDCl3): δ = 204.6 (C), 204.3
(C), 168.7 (C), 168.4 (C), 132.7 (CH), 132.4 (CH), 117.3 (CH2),
117.1 (CH2), 57.2 (CH), 56.8 (CH), 52.2 (CH2), 50.2 (CH2), 44.3
(CH2), 44.0 (CH2), 34.6 (CH3), 33.7 (CH3), 32.9 (CH2), 32.8 (CH2),
30.2 (CH2), 30.0 (CH2) ppm. 1H NMR (300 MHz, CDCl3): δ = General Procedure for the Preparation of Compounds in Table 3: To
5.84–5.69 (m, 2 H), 5.29–5.10 (m, 4 H), 4.17–3.65 (m, 6 H), 3.48–
3.33 (m, 2 H), 3.11–2.63 (m, 10 H), 2.97 (s, 3 H), 2.83 (s, 3 H) ppm.
MS (ESI+): m/z = 214 [M + H]+, 236 [M + Na]+, 252 [M + K]+.
a solution of 3 (0.50 mmol) in anhydrous dichloromethane (5 mL)
were successively added the acrylic derivative (0.50 mmol) and 5 in
two portions (0.015 mmol at the start, and 0.005 mmol after
20 min). The reaction vessel was sealed and irradiated with micro-
waves at 100 °C for 30 min (20, then 10 min). The solvent and vola-
tiles were removed under vacuum, and the resulting crude product
was purified by silica gel flash chromatography with EtOAc/petro-
leum ether to afford pure 2. Compounds 2b,[11b] 2c[11a] and 2f[23a]
exhibited physical and spectroscopic properties identical to pre-
viously reported data.
Compound 3f: According to the general procedure, 3f was obtained
as a colourless oil (159 mg, 65%). Rf (10% EtOAc in petroleum
ether) = 0.63. 13C NMR (75 MHz, CDCl3): keto form (ca. 30%):
δ = 200.4 (C), 170.0 (C), 141.2 (C), 138.0 (C), 132.4 (CH), 131.8
(CH), 129.8 (CH), 129.1 (CH), 126.7 (CH), 118.4 (CH2), 65.7
(CH2), 56.6 (CH), 32.8 (CH2), 25.3 (CH2), 24.3 (CH2); enol form
(ca. 70%): δ = 172.6 (C), 170.7 (C), 141.0 (C), 135.6 (C), 132.2
(CH), 130.1 (CH), 128.9 (CH), 127.1 (CH), 126.3 (CH), 117.9
Compound 2a: According to the general procedure, 2a was obtained
(CH2), 100.1 (C), 65.0 (CH2), 33.5 (CH2), 31.7 (CH2), 21.7 (CH2) as a brown oil (60 mg, 53%). Rf (25% EtOAc in petroleum ether)
1
ppm. H NMR (300 MHz, CDCl3): δ = 12.61 (s, 0.7 H), 7.78–7.59
(m, 1 H), 7.47–7.27 (m, 2 H), 7.25–7.17 (m, 1 H), 6.00 (dddd, J =
= 0.33. 13C NMR (75 MHz, CDCl3): δ = 211.7 (C), 168.6 (C), 166.2
(C), 140.8 (CH), 122.0 (CH), 63.2 (CH2), 54.6 (CH), 51.7 (CH3),
5.5, 6.7, 10.5, 16.0 Hz, 0.7 H), 5.91 (dddd, J = 5.8, 6.8, 10.5, 38.0 (CH2), 27.3 (CH2), 20.9 (CH2) ppm. 1H NMR (300 MHz,
16.1 Hz, 0.3 H), 5.41–5.22 (m, 2 H), 4.77–4.73 (m, 1.4 H), 4.70–
CDCl3): δ = 6.97–6.87 (m, 1 H), 6.12–6.05 (m, 1 H), 4.84–4.77 (m,
4.64 (m, 0.6 H), 3.89–3.82 (m, 0.3 H), 2.98–2.92 (m, 0.6 H), 2.65 2 H), 3.74 (s, 3 H), 3.22 (dd, J = 9.2, 9.0 Hz, 1 H), 2.44–2.24 (m,
(dd, J = 6.9, 6.5 Hz, 1.4 H), 2.27–2.01 (m, 3.7 H), 1.94–1.76 (m, 4 H), 2.20–2.08 (m, 1 H), 1.94–1.79 (m, 1 H) ppm. HRMS (ESI+):
+
0.3 H) ppm. MS (ESI+): m/z = 245 [M + H]+, 267 [M + Na]+, 283
m/z [M + H]+: calcd. for C11H15O5 227.0916, obsd 227.0920.
[M + K]+.
Compound 2d: According to the general procedure, 2d was obtained
as a brown oil (74 mg, 66%). Rf (30% EtOAc in petroleum ether)
= 0.45. 13C NMR (75 MHz, CDCl3): δ = 211.9 (C), 198.2 (C), 169.1
Compound 3g: According to the general procedure, 3g was obtained
as a colourless oil (186 mg, 63%). Rf (40% EtOAc in petroleum
ether) = 0.50. 13C NMR (75 MHz, CDCl3): δ = 203.9 (C), 203.6 (C), 142.7 (CH), 133.1 (CH), 62.9 (CH2), 54.6 (CH), 37.8 (CH2),
(C), 167.6 (C), 167.3 (C), 154.4 (2 C), 132.6 (CH), 132.3 (CH),
117.3 (2CH2), 80.7 (C), 80.6 (C), 53.6 (2 CH), 52.2 (2 CH2), 50.1
(2 CH2), 40.9 (2 CH2), 40.7 (2 CH2), 34.7 (2 CH3), 28.3 (6 CH3)
31.5 (CH2), 27.1 (CH2), 26.7 (CH3), 20.8 (CH2) ppm. 1H NMR
(300 MHz, CDCl3): δ = 6.73 (ddd, J = 6.8, 6.9, 16.0 Hz, 1 H), 6.09
(ddd, J = 1.3, 1.4, 16.0 Hz, 1 H), 4.32–4.16 (m, 2 H), 3.12 (dd, J =
9.2, 9.1 Hz, 1 H), 2.59–2.50 (m, 2 H), 2.30–2.01 (m, 5 H), 2.23 (s,
3 H), 1.90–1.74 (m, 1 H) ppm. MS (ESI+): m/z = 225 [M + H]+,
247 [M + Na]+, 263 [M + K]+.
1
ppm. H NMR (300 MHz, CDCl3): δ = 5.77 (dddd, J = 6.7, 6.9,
10.2, 17.2 Hz, 1 H), 5.75 (dddd, J = 6.7, 6.9, 10.2, 17.2 Hz, 1 H),
5.30–5.14 (m, 4 H), 4.30–3.83 (m, 6 H), 3.79–3.47 (m, 6 H), 3.40–
3.25 (m, 2 H), 2.95 (s, 3 H), 2.87 (s, 3 H), 2.64–2.39 (m, 4 H), 1.47
(s, 9 H), 1.46 (s, 9 H) ppm. MS (ESI+): m/z = 297 [M + H]+, 320
[M + Na]+, 336 [M + K]+.
Compound 2e: According to the general procedure, 2e was obtained
as a brown oil (104 mg, 78%). Rf (30% EtOAc in petroleum ether)
= 0.63. 13C NMR (75 MHz, CDCl3): δ = 211.1 (C), 169.2 (C), 166.4
(C), 143.8 (CH), 123.2 (CH), 62.9 (CH2), 54.0 (CH), 52.8 (CH2),
Compound 3h: According to the general procedure, 3h was obtained
as a colourless oil (151 mg, 77%). Rf (20% EtOAc in petroleum 51.4 (CH3), 40.6 (CH2), 34.3 (C), 31.2 (CH2), 28.8 (CH3), 27.5
1
ether) = 0.56–0.78. 13C NMR (75 MHz, CDCl3): keto form (ca.
40%): δ = 206.1 (C), 169.9 (C), 133.8 (CH), 117.2 (CH2), 64.0
(CH3) ppm. H NMR (300 MHz, CDCl3): δ = 6.9 (ddd, J = 6.9,
7.0, 15.8 Hz, 1 H), 5.90 (ddd, J = 1.2, 1.5, 15.8 Hz, 1 H), 4.35–4.15
(CH2), 57.1 (CH), 41.5 (CH2), 32.9 (CH2), 29.0 (CH2), 23.2 (CH2), (m, 2 H), 3.72 (s, 3 H), 3.36 (dd, J = 9.0, 11.0 Hz, 1 H), 2.64–2.28
22.3 (CH2); enol form (ca. 60%): δ = 172.5 (C), 172.1 (C), 133.9 (m, 3 H), 2.18 (s, 2 H), 2.21–1.97 (m, 1 H), 1.21 (s, 3 H), 1.04 (s, 3
Eur. J. Org. Chem. 2011, 5061–5070
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5067